Cision PR Newswire

This Week in Health News: 12 Stories You Need to See

News provided by

Nov 15, 2024, 6:12 AM ET

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including World Diabetes Day, breast cancer vaccine data and a celebrity C-suite appointment.

NEW YORK, Nov. 15, 2024 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed.

The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download.

World Diabetes Day: American Diabetes Association on the State of Diabetes
Throughout November the American Diabetes Association is raising awareness about diabetes and encouraging people to join in the fight for a cure. Learn your risk of developing type 2 diabetes and encourage friends and family to do the same.
American Workforce Burnout Reaches Tipping Point
American employers and employees are facing a conundrum: heightened levels of workplace stress and burnout. The 14th annual Aflac WorkForces Report uncovers very high levels of burnout are nearly twice as likely among U.S. Hispanic employees than non-Hispanics.
Zimmer Biomet Welcomes Arnold Schwarzenegger as Chief Movement Officer
"Arnold's bold approach to personal health, innovation and evolution echoes Zimmer Biomet's vision to be the boldest company in MedTech by solving the most meaningful problems in healthcare today," said Ivan Tornos, President and Chief Executive Officer of Zimmer Biomet. "People are seeking to lead healthier, more active lifestyles as they age, and the demand for people to keep moving pain-free is increasing."
U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial
The FDA has cleared the Company to begin enrolling the planned Phase 3 trial following the determination that Novavax satisfactorily addressed all clinical hold issues. Novavax will be working with the clinical trial investigators and other partners to resume trial activities as quickly as possible.
Cardinal Health Announces Two Strategic Additions to its Portfolio
Cardinal Health will acquire majority stakes in GI Alliance, the country's leading gastroenterology management services organization, and the Advanced Diabetes Supply Group, one of the country's leading diabetic medical supplies providers. The company plans to hold an Investor Day in June 2025.
Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Anixa's breast cancer vaccine was safe and well tolerated by participants in all 3 cohorts of the Phase 1 study. A Phase 2 study evaluating the vaccine in the neoadjuvant setting is planned to commence in 2025.
Stand Up To Cancer Collaborates with Johnson & Johnson to Explore Targeted Therapies for Rare Disease Linked to Blood Cancers
The collaboration is aimed at supporting research to test a combination of targeted therapies, teclistamab and daratumumab, to treat a rare disease called AL amyloidosis. Affecting approximately 4,500 people annually in the U.S., AL amyloidosis can be associated with blood cancers, particularly multiple myeloma as well as lymphomas or chronic lymphocytic leukemia.
US Earns D+ for Preterm Birth Rate for Third Consecutive Year in 2024 March of Dimes Report Card, Remaining Worst Grade in Report History
The 2024 Report Card reveals over 370,000 babies were born preterm in 2023, with one-third of the largest US cities receiving an F grade for preterm birth rates. Twenty-four states experienced worsening rates, many in the southeastern US, with Black birthing people facing preterm birth rates 1.4 times higher than their peers.
Havas Hosts "GLP101 Day," Connecting the Dots for Today and Tomorrow's GLP-1 Users
Leading global communications network Havas hosted its inaugural "GLP101 Day" conference to showcase a holistic view of GLP-1 drugs. As these therapies continue to change the landscape of weight management and metabolic health, their potential impacts extend far beyond physical transformation.
Zucara Therapeutics Announces Strategic Investment from Sanofi as Part of US$20 Million Series B Financing
Zucara, a diabetes life sciences company developing ZT-01, the first once-daily therapeutic to prevent hypoglycemia (low blood glucose levels) in people with diabetes, announced that Sanofi has made a strategic investment in Zucara as part of the Company's US$20 million Series B financing. As part of the agreement, Sanofi will receive an exclusive right of first negotiation.
The National Medical Association Partners with the U.S. Department of Health and Human Services on "Risk Less. Do More." Public Education Campaign
The educational campaign was developed to increase awareness and reduce hesitancy surrounding immunizations of pan respiratory viral infections. Launched during National Immunization Awareness Month in August, the campaign is more relevant than ever as the winter season approaches.
New Evidence-Based Information from NCCN Offers Tangible and Moral Support for People Trying to Quit Smoking
The National Comprehensive Cancer Network published new patient guidelines for individuals with cancer who are seeking to quit smoking. While focused on cessation strategies in people with cancer, the information is also useful for smokers who do not have a cancer diagnosis and want to quit for good.

For more news like this, check out all of the latest health-related releases from PR Newswire.

Do you have a health press release to distribute? Sign up with PR Newswire to share your story with the audiences who matter most.

Veterans Day

Veterans Day was observed on November 11. Here is a roundup of health news we saw honoring veterans this week:

Read more Veterans Day releases here.

Helping Journalists Stay Up to Date on Industry News

These are just a few of the recent press releases that consumers and the media should know about. To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists.

Once they're signed up, reporters, bloggers, and freelancers have access to the following free features:

Customization: Users can create customized newsfeeds that will deliver relevant news right to their inbox. Newsfeed results can be targeted by keywords, industry, subject, geography, and more.
Photos and Videos: Thousands of multimedia assets are available to download and include in a journalist or blogger's next story.
Subject Matter Experts: Journalists will have access to ProfNet, a database of industry experts to connect with as sources or for quotes in their articles.
Related Resources: Our journalist- and blogger-focused blog, Beyond Bylines, features regular media news roundups, writing tips, upcoming events, and more.

About PR Newswire

PR Newswire is the industry's leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.

For questions, contact the team at media.relations@cision.com.